SHPPF:OTC-Shop Apotheke Europe N.V (USD)

COMMON STOCK | Pharmaceutical Retailers |

Last Closing

USD 139.16

Change

-20.84 (-13.03)%

Market Cap

USD 3.20B

Volume

198.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
JDHIY JD Health International Inc

N/A

USD 12.19B
JDHIF JD Health International Inc

N/A

USD 10.00B
ALBHF Alibaba Health Information Tec..

-0.01 (-3.26%)

USD 8.29B
RADLY Raia Drogasil SA ADR

-0.10 (-2.67%)

USD 7.12B
CLCGY Clicks Group Ltd

-0.23 (-0.58%)

USD 5.27B
SAEYY Shop Apotheke Europe N.V

N/A

USD 2.88B
NOTR Nowtransit Inc

N/A

USD 0.55B
ZRSEF Zur Rose Group AG

-15.17 (-38.86%)

USD 0.46B
PNPL Pineapple Express

N/A

USD 0.01B
RLLVF Relevium Technologies Inc

N/A

USD 5.33M

ETFs Containing SHPPF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 192.05% 100% F 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 192.05% 100% F 95% A
Trailing 12 Months  
Capital Gain 192.05% 100% F 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 192.05% 100% F 95% A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 20.00% 67% D+ 64% D
Dividend Return 20.00% 67% D+ 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 96.62% 50% F 35% F
Risk Adjusted Return 20.70% 67% D+ 55% F
Market Capitalization 3.20B 75% C 83% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.